技术指标
指标
数值
方向
MACD(12,26,9)
-0.101
卖出
RSI(14)
42.565
中性
STOCH(KDJ)(9,3,3)
15.933
超卖
ATR(14)
0.534
低波动
CCI(14)
-90.847
中性
Williams %R
87.912
超卖
TRIX(12,20)
-0.197
卖出
StochRSI(14)
19.894
超卖
搜索
Burning Rock Biotech Ltd
BNR添加自选
8.900USD
-0.050-0.56%
收盘 07-31 16:00（美东）报价延迟15分钟
80.36M总市值
亏损市盈率 TTM
关键数据
9.060今开
9.060最高
1.47K成交量
亏损市盈率 TTM
--市盈率动
--股息TTM
0.02%换手率
8.850昨收
8.875最低
10.15K成交额
亏损市盈率静
1.05市净率
0.00%股息率 TTM
-6.49%ROA
41.72052周最高
0.96量比
-346.63M净利润
9.03M总股本
-0.7445每股收益TTM
1.38Beta
-9.92%ROE
2.80052周最低
2.09%振幅
72.27%毛利率
80.36M总市值
-1.89回报/风险
7.58%风险率
TradingKey Burning Rock Biotech Ltd股票评分
单位: USD 更新时间: 2026-07-31操作建议
Burning Rock Biotech Ltd当前公司基本面数据相对非常健康，增长潜力很大。当前估值合理，在医疗服务供应商行业排名58/75位。机构持股占比非常高，中期看，股价处于下降通道。近一个月，市场表现较差，但基本面评分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
Burning Rock Biotech Ltd评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
中性
Burning Rock Biotech Ltd亮点
亮点风险
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
业绩增长期
公司处于发展阶段，最新年度总收入78.24M美元
估值低估
公司最新PE估值-11.95，处于3年历史低位
机构减仓
最新机构持股4.03M股，环比减少6.43%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓，最新持仓市值0.00
分析师目标
根据
0
位分析师
--
评级
--
目标均价
--
涨幅空间
Burning Rock Biotech Ltd新闻
即将为您带来更多新闻，敬请期待。。。
技术指标
移动平均线
指标
数值
方向
MA5
9.032
卖出
MA10
9.199
卖出
MA20
9.865
卖出
MA50
9.712
卖出
MA100
13.971
卖出
MA200
17.727
卖出
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Burning Rock Biotech Ltd简介
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
公司代码BNR
公司Burning Rock Biotech Ltd
CEOHan (Yusheng)
网址https://www.brbiotech.com/
公司股东
相关品种
-1.72%
-0.43%
+0.12%
-0.59%
-0.74%
+0.10%
-6.42%
-0.36%
+1.75%
-0.14%
-2.99%
+1.58%
-0.29%
-1.02%
+0.13%
+0.05%
-0.80%
-0.24%
-0.70%
-0.78%热门品种
常见问题
Burning Rock Biotech Ltd(BNR)的当前股价是多少？
Burning Rock Biotech Ltd(BNR)的当前股价是 8.90。
Burning Rock Biotech Ltd的股票代码是什么？
Burning Rock Biotech Ltd的股票代码是BNR。
Burning Rock Biotech Ltd股票的52周最高点是多少？
Burning Rock Biotech Ltd股票的52周最高点是41.72。
Burning Rock Biotech Ltd股票的52周最低点是多少？
Burning Rock Biotech Ltd股票的52周最低点是2.80。
Burning Rock Biotech Ltd的市值是多少？
Burning Rock Biotech Ltd的市值是80.36M。
Burning Rock Biotech Ltd(BNR)股票的每股收益（EPS TTM）是多少
Burning Rock Biotech Ltd(BNR)股票的每股收益（EPS TTM）是-0.74。